BLST Northstar, LLC v. Santander Consumer USA, Inc.: Date Argued: February 12th, 2026, Docket Number: 24-3597

Case Summary: In the case of BLST Northstar, LLC v. Santander Consumer USA, Inc. (Docket No. 24-3597), argued before the U.S. Court of Appeals for the Eighth Circuit on February 12, 2026, the relevant facts are as follows:The litigation arose from a multi-year commercial financing relationship between the plaintiffs (collectively Bluestem) and Santander Consumer USA, where Santander provided the liquidity to fund Bluestem’s consumer credit program by purchasing its accounts receivable.Bluestem alleged that their underlying contracts provided them with a right of first refusal to repurchase these receivables—valued at over $1 billion—in the event that Santander decided to exit the program or the contracts were not renewed.The factual dispute centered on Santander’s decision in March 2021 to sell and assign the entire portfolio of receivables to a third party (BB Allium) without first allowing Bluestem to exercise its purported buy-back rights.Bluestem contended that Santander not only breached the contract but also violated the Defend Trade Secrets Act (DTSA) by disclosing sensitive financial performance data and future business plans to the third-party buyer to facilitate the sale.Santander maintained that the written agreements granted them an express and absolute right to sell or transfer their ownership interest in the receivables at any time and that no "right of first refusal" was explicitly mentioned in the final signed documents.In November 2024, a district court granted summary judgment in favor of Santander, ruling that the contracts were unambiguous and that Bluestem could not use "intent" or extrinsic evidence to contradict the plain language of the agreements.The current appeal, docketed as 24-3597, challenges that ruling, with Bluestem arguing that the trial court ignored industry-standard interpretations of terms like "encumber" and "securitization" that they claim restricted Santander's ability to sell to a competitor.During the oral arguments on February 12, 2026, the Eighth Circuit panel examined whether the "merger clause" in the parties' contract legally barred the consideration of pre-agreement negotiations that Bluestem claimed established the buy-back right.